Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |